Our pipeline targets phosphoinositide 3-kinase (PI3K-delta/gamma) and focal adhesion kinase (FAK).

 

PI3K Inhibitor 

Verastem Oncology Pipeline

 

FAK Inhibitor 

Verastem Oncology FAK Inhibition Pipeline

 

Learn more about our clinical trials